ARTICLE | Financial News
Galmed raises $75M follow-on
June 22, 2018 7:01 PM UTC
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) raised $75 million through the sale of 5 million shares at $15 in a follow-on underwritten by Stifel, SunTrust Robinson Humphrey, Cantor Fitzgerald, Raymond James, Roth Capital Partners, Maxim Group and Seaport Global Securities.
The price is a tiny premium to Galmed's close of $14.91 on June 18, when it proposed after market hours to raise $75 million...
BCIQ Company Profiles